Z17.21
ICD-10-CMThis code indicates that a patient's tumor cells have tested positive for progesterone receptors (PR). The presence of PR suggests that the cancer may be hormone-sensitive and potentially responsive to endocrine therapies. It is a crucial biomarker in the management of certain cancers, particularly breast cancer.
Use this code when laboratory or pathology reports confirm the presence of progesterone receptors in a tumor biopsy or surgical specimen. This is commonly documented for patients diagnosed with breast cancer to guide treatment decisions. It may also be relevant in other hormone-sensitive cancers where PR status is assessed.
AI-generated reference — verify against official guidelines
Inclusion Terms
+5 more in this category